- ICH GCP
- Registro de ensayos clínicos de EE. UU.
- Ensayo clínico NCT07758959
Comparison of Purse String Suture vs Transverse Mattress Suture to Maintain Hemostasis in Thinned-out Caesarean Sections Scars
Brief Summary The goal of this clinical trial is to compare the effectiveness of purse-string suture versus transverse mattress suture for achieving hemostasis in women with thinned-out lower uterine segment scars undergoing repeat cesarean section. The study aims to determine whether the purse-string suture technique provides faster and more effective hemostasis than the transverse mattress suture technique.
The main questions it aims to answer are:
- Does the purse-string suture reduce the time required to achieve hemostasis compared with the transverse mattress suture?
- Does the purse-string suture reduce the number of additional sutures required to achieve adequate hemostasis? Researchers will compare purse-string suturing with transverse mattress suturing to determine which technique achieves hemostasis more efficiently in women with thinned-out cesarean section scars.
Participants will:
- Undergo repeat cesarean section under standard surgical care.
- Be randomly assigned to receive either purse-string suturing or transverse mattress suturing for repair of the thinned-out lower uterine segment after closure of the first uterine layer.
- Have the time required to achieve hemostasis and the number of sutures required recorded intraoperatively.
- Receive routine postoperative management according to institutional protocols. Suggested improvement
Although the thesis mentions only time to achieve hemostasis and number of sutures as outcomes, ClinicalTrials.gov prefers that the primary outcome be clearly identified. Since your sample size was calculated using time to achieve hemostasis, I recommend presenting it as:
- Primary outcome: Time to achieve hemostasis (minutes)
- Secondary outcomes: Number of sutures required for hemostasis; duration of cesarean section (minutes)
Descripción general del estudio
Estado
Intervención / Tratamiento
Tipo de estudio
Inscripción (Actual)
Fase
- No aplica
Contactos y Ubicaciones
Ubicaciones de estudio
-
-
Punjab Province
-
Lahore, Punjab Province, Pakistán, 54070
- Lahore General Hospital
-
-
Criterios de participación
Criterio de elegibilidad
Edades elegibles para estudiar
- Adulto
Acepta Voluntarios Saludables
Descripción
Inclusion Criteria:
- Females aged 18 to 40 years.
- Gestational age >37 weeks at the time of delivery.
- Parity <5.
- History of one or more previous cesarean sections.
- Intraoperative evidence of a thinned-out lower uterine segment scar during repeat cesarean section.
Exclusion Criteria:
- Preeclampsia (blood pressure ≥140/90 mmHg with proteinuria >+1 on dipstick).
- Gestational diabetes mellitus.
- Placental abnormalities, including placenta previa, placenta accreta spectrum (accreta/increta), or placental abruption.
- Previous uterine repair scar.
- Coagulation disorder (prothrombin time >15 seconds).
Plan de estudios
¿Cómo está diseñado el estudio?
Detalles de diseño
- Propósito principal: Tratamiento
- Asignación: Aleatorizado
- Modelo Intervencionista: Asignación paralela
- Enmascaramiento: Ninguno (etiqueta abierta)
Armas e Intervenciones
Grupo de participantes/brazo |
Intervención / Tratamiento |
|---|---|
|
Experimental: Arm 1 Arm Title: Purse-String Suture
Participants undergoing repeat cesarean section with a thinned-out lower uterine segment scar underwent uterine repair using the purse-string suture technique to achieve hemostasis.
|
Purse-string suturing of the thinned-out lower uterine segment during repeat cesarean section.
|
|
Experimental: Arm 2 Arm Title: Transverse Mattress Suture
Participants undergoing repeat cesarean section with a thinned-out lower uterine segment scar underwent uterine repair using the transverse mattress suture technique to achieve hemostasis.
|
Transverse mattress suturing of the thinned-out lower uterine segment during repeat cesarean section.
|
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Time to Achieve Hemostasis
Periodo de tiempo: During the surgical procedure (intraoperative)
|
Time (in minutes) required to achieve complete hemostasis of the thinned-out lower uterine segment following application of the assigned suturing technique during repeat cesarean section.
|
During the surgical procedure (intraoperative)
|
|
Time to Achieve Hemostasis
Periodo de tiempo: Intraoperative (during cesarean section)
|
Time (in minutes) required to achieve complete hemostasis of the thinned-out lower uterine segment following application of the assigned suturing technique during repeat cesarean section.
|
Intraoperative (during cesarean section)
|
Medidas de resultado secundarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Number of Sutures Required to Achieve Hemostasis
Periodo de tiempo: Intraoperative (during cesarean section)
|
Number of hemostatic sutures required to achieve complete hemostasis of the thinned-out lower uterine segment during repeat cesarean section.
|
Intraoperative (during cesarean section)
|
Colaboradores e Investigadores
Patrocinador
Colaboradores
Fechas de registro del estudio
Fechas importantes del estudio
Inicio del estudio (Actual)
Finalización primaria (Estimado)
Finalización del estudio (Estimado)
Fechas de registro del estudio
Enviado por primera vez
Primero enviado que cumplió con los criterios de control de calidad
Publicado por primera vez (Actual)
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
Última actualización enviada que cumplió con los criterios de control de calidad
Última verificación
Más información
Términos relacionados con este estudio
Palabras clave
Otros números de identificación del estudio
- lahore general hospital
- irb no 199/24 (Otro identificador: lahore general hospital)
Plan de datos de participantes individuales (IPD)
¿Planea compartir datos de participantes individuales (IPD)?
Descripción del plan IPD
Información sobre medicamentos y dispositivos, documentos del estudio
Estudia un producto farmacéutico regulado por la FDA de EE. UU.
Estudia un producto de dispositivo regulado por la FDA de EE. UU.
producto fabricado y exportado desde los EE. UU.
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .